🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

9,250 results for “IO” Clear

  1. Leuprorelin

    Takeda

    Central Precocious Puberty

    approved small molecule completed

    1 trial

  2. Leuprorelin Acetate Depot 3M

    Takeda

    Central Precocious Puberty

    approved small molecule completed

    1 trial

  3. Levocarnitine Injection

    The First People's Hospital of Lianyungang

    Renal Dialysis

    approved small molecule completed

    1 trial

  4. Levofloxacin

    Hospital Authority, Hong Kong

    Urinary Tract Infection

    approved small molecule active

    1 trial

  5. Levosimendan Kalceks 2,5 mg/ml concentraat voor oplossing voor infusie, Soluvit N poeder voor oplossing voor intraveneuze infusie

    Disc Medicine

    Failure to wean from invasive ventilation.

    approved small molecule active

    1 trial

  6. Linaclotide

    IRONWOOD PHARMACEUTICALS INC

    Irritable Bowel Syndrome Characterized by Constipation

    approved small molecule completed

    2 trials

  7. Linaclotide

    IRONWOOD PHARMACEUTICALS INC

    Irritable Bowel Syndrome With Constipation

    approved small molecule completed

    3 trials

  8. Liposomal Bupivacaine Infiltration

    Pacira Ireland Limited

    Postoperative Pain

    approved small molecule terminated

    1 trial

  9. Liraglutide

    Sana Biotechnology

    Morbid Obesity

    approved small molecule completed

    1 trial

  10. Lisdexamfetamine dimesylate

    Takeda

    Attention-deficit/Hyperactivity Disorder

    approved small molecule completed

    3 trials

  11. Lisdexamfetamine dimesylate

    Takeda

    Attention Deficit Hyperactivity Disorder (ADHD)

    approved small molecule completed

    1 trial

  12. Lithium Carbonate 250 MG

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sleep Deprivation

    approved small molecule completed

    1 trial

  13. Live Combined Bifidobacterium and Lactobacillus

    The First People's Hospital of Lianyungang

    Functional Constipation

    approved small molecule active

    1 trial

  14. Livmarli 9.5 mg/mL oral solution

    Lacuna Pharma Pty Ltd

    Progressive Familial Intrahepatic Cholestasis, Alagille syndrome

    approved small molecule active

    1 trial

  15. Livmarli Oral Product

    Mirum Pharmaceuticals International B.V.

    Alagille Syndrome

    approved small molecule active

    1 trial

  16. Lixiana 30 mg film-coated tablets, Lixiana 60 mg film-coated tablets

    The George Institute

    High risk atrial fibrillation patients with previous intracranial hemorrhage

    approved small molecule active

    1 trial

  17. Lotilaner ophthalmic solution, 0.25%

    Tarsus Pharmaceuticals

    Demodex Blepharitis

    approved small molecule completed

    1 trial

  18. Low-Molecular-Weight Heparins Calcium Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pneumonia

    approved small molecule completed

    1 trial

  19. Lubiprostone

    Takeda

    Constipation

    approved small molecule completed

    7 trials

  20. Lucentis

    Hospital Authority, Hong Kong

    Wet Macular Degeneration

    approved small molecule completed

    1 trial

  21. Lutrate Depot Trimestral 22,5 mg polvo y disolvente para suspensión inyectable de liberación prolongada, Verzenios 150 mg film-coated tablets, Femara 2.5 mg Tablets, Arimidex® 1 mg film-coated tablets, Zoladex 10,8 mg implantat, Aromasil 25 mg comprimidos recubiertos, Verzenios 100 mg film-coated tablets, Zoladex 3,6 mg implantat, Kisqali 200 mg film-coated tablets, Lutrate Depot Mensual 3,75 mg polvo y disolvente para suspensión inyectable de liberación prolongada, Verzenios 50 mg film-coated tablets

    Ningbo Cancer Hospital

    Early Breast Cancer

    approved small molecule active

    1 trial

  22. MAXIGRA, 100 mg, tabletki powlekane

    Lacuna Pharma Pty Ltd

    Erectile dysfunction

    approved small molecule active

    1 trial

  23. METHADONE , Suboxone 2 mg/0.5 mg sublingual tablets

    Disc Medicine

    Opioid use disorder (DSM-5); chronic non-cancer pain (ICD-11).

    approved small molecule active

    1 trial

  24. METHOTREXATE , MYCOPHENOLIC ACID , AZATHIOPRINE , Tavneos 10 mg hard capsules, CYCLOPHOSPHAMIDE , -, RITUXIMAB, Placebo for AMG 569

    Amgen

    Antineutrophil cytoplasmic antibody-associated vasculitis (AAV)

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources